Efficacy and safety of antifungal additives in Optisol-GS corneal storage medium
| Autor: | Jeremy D. Keenan, Vicky Cevallos, Noelle Layer, Bennie H. Jeng, Caroline K. Hoover, Andrew J. Maxwell |
|---|---|
| Rok vydání: | 2014 |
| Předmět: |
Antifungal Agents
Endothelium Organ Preservation Solutions Colony Count Microbial Candida glabrata Cell Count Microbial Sensitivity Tests Complex Mixtures Vial Culture Media Serum-Free Microbiology Cornea Endophthalmitis Amphotericin B Candida albicans medicine Humans Voriconazole biology business.industry Chondroitin Sulfates Endothelium Corneal Candidiasis Dextrans Organ Preservation Triazoles biology.organism_classification medicine.disease Tissue Donors Staining Ophthalmology Drug Combinations medicine.anatomical_structure Pyrimidines Treatment Outcome Gentamicins business Drug Contamination medicine.drug |
| Zdroj: | JAMA ophthalmology. 132(7) |
| ISSN: | 2168-6173 |
| Popis: | Importance Optisol-GS, the most common corneal storage medium in the United States, contains antibacterial but no antifungal supplementation. Most postkeratoplasty endophthalmitis and keratitis cases are now of a fungal origin. Objective To assess the efficacy and safety of voriconazole and amphotericin B in reducing Candida species contamination of Optisol-GS under normal storage conditions. Design, Setting, and Participants In vitro laboratory study using 15 pairs of research-grade donor corneas and 20-mL vials of Optisol-GS. Interventions Twenty vials of Optisol-GS were supplemented with either voriconazole at 1×, 10×, 25×, or 50× minimum inhibitory concentration (MIC) or amphotericin B at 0.25×, 0.5×, 1×, or 10× MIC. Known concentrations of Candida albicans and Candida glabrata were each added to a set of vials. Safety studies were performed by separating 15 pairs of donor corneas into unsupplemented Optisol-GS or Optisol-GS plus an antifungal. Main Outcomes and Measures Efficacy outcomes were viable fungal colony counts determined from samples taken on days 2, 7, and 14 immediately after removal from refrigeration and after warming to room temperature for 2 hours. Safety outcomes included percentage of intact epithelium and endothelial cell density on days 0, 7, and 14, as well as percentage of nonviable endothelial cells by vital dye staining on day 14. Results Growth of C albicans and C glabrata was observed in all voriconazole-supplemented vials. In contrast, there was no growth of either organism in amphotericin B–supplemented vials, except at 0.25× and 0.5× MIC on day 2, when viable counts of C glabrata were reduced by 99% and 96%, respectively. Compared with paired controls, with the exception of Optisol-GS plus amphotericin B at 10× MIC, donor corneas in supplemented Optisol-GS appeared to have no difference in endothelial cell density reduction, percentage of intact epithelium, or percentage of nonviable endothelial cells. Conclusions and Relevance The addition of amphotericin B to Optisol-GS may significantly improve activity against contamination with Candida species, the primary cause of fungal infection after corneal transplantation. This study found significant endothelial toxic effects at the maximal concentration of amphotericin B. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|